Comparison of Two Shiga Toxin-producing Escherichia coli (STEC) Isolation Protocols in Raw Cow's Milk Cheese Enrichment Broths: Direct STEC Isolation Versus Techniques Based on Immuno-concentration.


Journal

Journal of food protection
ISSN: 1944-9097
Titre abrégé: J Food Prot
Pays: United States
ID NLM: 7703944

Informations de publication

Date de publication:
09 2023
Historique:
received: 22 11 2022
revised: 03 07 2023
accepted: 07 07 2023
medline: 1 9 2023
pubmed: 14 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

The presence of Shiga toxin-producing Escherichia coli (STEC) in dairy products made with raw milk is a major concern for food safety authorities and industries. Two approaches have been proposed to isolate STEC from food. In the IC-Protocol (immuno-concentration protocol), specific serogroups are identified in the enrichment broth after the detection of the stx and eae genes. An immuno-concentration of the targeted serogroups is performed before isolating them on specific media. In the DI-Protocol (direct isolation protocol), a direct isolation of all STEC present in the enrichment broth is carried out after the detection of stx genes. We compared the ability of these two methods to isolate STEC O26:H11, O103:H2, O111:H8, O145:H28, and O157:H7 after artificial inoculation in four different raw milk cheeses. Across all serogroups and cheese types, STEC were isolated in 83.3% of samples when using the IC-Protocol but only 53.3% of samples with the DI-Protocol. For two cheese types, the DI-Protocol failed to isolate STEC O157:H7 strains altogether. Our results suggest that IC-Protocol is a robust methodology to effectively isolate STEC across a range of cheese types.

Identifiants

pubmed: 37442229
pii: S0362-028X(23)06812-6
doi: 10.1016/j.jfp.2023.100128
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100128

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Stephane D Miszczycha (SD)

Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Laboratoire d'Étude des Microorganismes Alimentaires Pathogènes, French National Reference Laboratory for Escherichia coli including Shiga Toxin-Producing E. coli, Marcy l'Etoile, France.

Christine Mazuy-Cruchaudet (C)

Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Laboratoire d'Étude des Microorganismes Alimentaires Pathogènes, French National Reference Laboratory for Escherichia coli including Shiga Toxin-Producing E. coli, Marcy l'Etoile, France; Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Research Group on Bacterial Opportunistic Pathogens and Environment, UMR 5557 Ecologie Microbienne CNRS, VetAgro Sup, and Université Lyon 1, Lyon, France.

Camille Thollet (C)

Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Laboratoire d'Étude des Microorganismes Alimentaires Pathogènes, French National Reference Laboratory for Escherichia coli including Shiga Toxin-Producing E. coli, Marcy l'Etoile, France.

Delphine Sergentet-Thevenot (D)

Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Laboratoire d'Étude des Microorganismes Alimentaires Pathogènes, French National Reference Laboratory for Escherichia coli including Shiga Toxin-Producing E. coli, Marcy l'Etoile, France; Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Research Group on Bacterial Opportunistic Pathogens and Environment, UMR 5557 Ecologie Microbienne CNRS, VetAgro Sup, and Université Lyon 1, Lyon, France. Electronic address: delphine.sergentet@vetagro-sup.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH